Emyria Limited
EMD
Rank in Stocks
#26467
Emyria Limited is a biotechnology firm currently in the clinical stage,... Emyria Limited is a biotechnology firm currently in the clinical stage, dedicated to creating therapies for medical conditions that lack effective treatments. The company's work primarily involves the development of cannabinoid-derived pharmaceuticals, alongside an initiative for discovering new MDMA-based drugs. Among its pipeline, EMD-RX5 is being explored for psychological distress and irritable bowel syndrome, while EMD-RX7 targets a variety of medical conditions. Established in 2018 and based in Leederville, Australia, the company adopted its current name, Emyria Limited, in September 2020, having previously operated as Emerald Clinics Limited.
Share Price
$0.02491884
Last synced: 2026-11-10
Market Cap
$20.10M
Change (1 day)
0.00%
Change (1 year)
-48.40%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Emyria Limited (EMD)
Category
Healthcare
Operating Margin for Emyria Limited (EMD)
Operating Margin as of November 2026 TTM: -161.58%
According to Emyria Limited's latest financial reports, its current operating margin (TTM) is -161.58%. At the end of 2025 the company had an operating margin of -189.66%.
Operating Margin history for Emyria Limited from 2018 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -161.58% | -14.81% |
| 2025 | -189.66% | -39.48% |
| 2024 | -313.37% | -29.89% |
| 2023 | -446.97% | -4.60% |
| 2022 | -468.52% | 62.11% |
| 2021 | -289.02% | -47.98% |
| 2020 | -555.64% | -77.45% |
| 2019 | -2,463.52% | 0.00% |
| 2018 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 13.21% | -100.08% |
US
|
|
| -19.76% | -99.88% |
US
|
|
| 74.94% | -100.46% |
AU
|
|
| 3.61% | -100.02% |
US
|
|
| 13.01% | -100.08% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Emyria Limited's operating margin
What is Emyria Limited's operating margin?
Emyria Limited's operating margin is -161.58%, as of Nov 2026.
What was Emyria Limited's operating margin in 2025?
In 2025, Emyria Limited's operating margin was -189.66%, compared with -313.37% in 2024.
How has Emyria Limited's operating margin changed since 2020?
From 2020 to 2025, Emyria Limited's operating margin was highest in 2025 (-189.66%) and lowest in 2020 (-555.64%).
How does Emyria Limited's operating margin compare with similar companies?
Emyria Limited's operating margin (-161.58%) is lower than that of all 5 similar companies listed above. The highest among them is Pro Medicus Limited, with 74.94%.